NASDAQ: CJMBCallan Jmb Inc Stock Ownership - Who owns Callan Jmb?
Insider buying vs selling
Have Callan Jmb Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David J. Croyle | Chief Medical Officer | 2025-03-27 | 25,000 | $4.50 | $112.50kBuy |
| David J. Croyle | Chief Medical Officer | 2025-02-05 | 24,375 | $4.00 | $97.50kBuy |
| Wayne D. Williams | CEO and President | 2025-02-05 | 12,500 | $4.00 | $50.00kBuy |
| Wayne D. Williams | CEO and President | 2025-02-05 | 25,625 | $4.00 | $102.50kBuy |
| Wayne D. Williams | CEO and President | 2025-02-05 | 25,000 | $4.00 | $100.00kBuy |
CJMB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CJMB insiders and whales buy or sell their stock.
CJMB Shareholders
What type of owners hold Callan Jmb Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Wayne D. Williams | 51.34% | 2,300,625 | $11.92M | Insider |
| David J. Croyle | 34.58% | 1,549,375 | $8.03M | Insider |
| Bard Associates Inc | 8.82% | 395,035 | $2.05M | Institution |
| Cable Car Capital LP | 2.92% | 130,862 | $677.87k | Institution |
| Creative Planning | 2.68% | 120,008 | $621.64k | Institution |
| Ubs Group Ag | 0.62% | 27,568 | $142.80k | Institution |
| Hightower Advisors LLC | 0.28% | 12,500 | $64.75k | Institution |
| Geode Capital Management LLC | 0.26% | 11,748 | $60.85k | Institution |
| Valley National Advisers Inc | 0.05% | 2,250 | $11.66k | Institution |
| Tower Research Capital LLC Trc | 0.02% | 979 | $5.07k | Institution |
CJMB vs App Stocks
Callan Jmb Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.